|
CHECK OUT OUR LATEST ISSUE
The trend for alternative treatment approaches in dermatology is on the rise, particularly among those patients whose disease or condition is recalcitrant to standard conventional therapies.
» Full article
|
|
The American Academy of Dermatology (AAD) Council on Science and Research’s Research Agenda work group has identified three keys areas — pruritus, cutaneous oncology and performance measurement and outcomes — to target in the future for continuing research in the dermatology specialty.
» Full article
|
|
Popular media coverage of purported links between isotretinoin and inflammatory bowel disease (IBD) are largely overblown, as are patients’ concerns regarding the risks of oral contraceptive pills (OCPs) for acne, according to an expert.
» Full article
|
|
Analyses of data collected through one year of follow-up in two phase 3 clinical trials demonstrated that ustekinumab was associated with significantly greater improvements in joint, tissue and skin manifestations after 24 weeks compared with placebo, had durable or increasing efficacy with ongoing quarterly injections, and provided benefit for individuals previously treated with a tumor necrosis factor-alpha (TNF-alpha) inhibitor.
» Full article
|
|
Treating existing scars can help dermatologists and other core aesthetic specialists build lasting relationships with patients, says an expert who spoke at Cosmetic Boot Camp in Aspen, Colo.
» Full article
|
|
|
Like
Tweet
